CIGNA HealthCare is teaming up with the non-profit organization HopeLab to deliver innovative interventions that improve the health and quality of life of young people with chronic illnesses.
WHO and UNAIDS issued new guidance on informed, voluntary HIV testing and counselling in the world’s health facilities, with a view to significantly increasing access to needed HIV treatment, care, support and prevention services.
Pfizer Inc announced that the National Institute for Health and Clinical Excellence (NICE) in the United Kingdom has recommended Champix (varenicline) for use on the National Health Service for adult smokers who have expressed a desire to quit.
A new study showing a reduction in the toxic side effects of ROS-generating chemotherapies with concurrent antioxidant supplementation will be presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) that takes place June 1-5 at McCormick Place in Chicago.
If two dogs are any indication, Iowa State University veterinary researchers may have found a cure for a previously incurable disease that causes dogs to go blind suddenly.
Subtle racism ? which can include social slights and ambiguous remarks that are hard to pin down ? is more dangerous to mental health than overt discrimination, according to a study of 180 Korean immigrants living in Canada.
The general public are worryingly ignorant about the symptoms and risk factors that contribute to serious medical conditions such as stroke and HIV/AIDS, according to a study published in the online open access journal BMC Medicine.
Brain damage that occurs even days after a stroke, increasing stroke size and devastation, is the focus of researchers trying to identify new treatments.
In one of the three most common back conditions for which patients seek treatment, surgery proved to have substantially better results than non-surgical remedies, according to Dartmouth-led research published in the May 31 New England Journal of Medicine.
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease.